
    
      Upon obtaining informed consent, patients will begin two courses of oral cyclophosphamide and
      topotecan x 14 days. During the first of two courses, patients will perform the
      14C-Erythromycin Breath Test and have topotecan pharmacokinetics performed on day 1 and 14.
      The subjects will also have various medical tests and procedures performed that are part of
      regular cancer care which include: Medical history and physical examination to be done
      weekly, blood tests to be done weekly, heart and kidney function tests, various scans to be
      done after two courses of treatment, and a pregnancy test for females of childbearing age to
      be done prior to starting treatment.

      Patients may continue to receive additional courses of oral cyclophosphamide and topotecan
      provided that they do not experience tumor progression or intolerable side effects.
    
  